Patents

Optimata Virtual Patient Approved as a Registered Trademark

Published in Medical Patent Business Week, May 11th, 2007

Optimata Ltd. announced that the Optimata Virtual Patient(R) (OVP) has been approved as a registered trademark by the US Patent & Trademark Office. The company also announced the launch of a new module to simulate and optimize targeted therapy agents.

"Trademark approval is an appropriate acknowledgment of our position as a world leader in the development of biosimulation technologies," said Guy Malchi, CEO of Optimata.

Commenting on the recent launch of the targeted therapeutics module he added: "This is a new product that enables improved predictions and better optimization for the impact and side effects of novel targeted therapy agents,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Patent Business Week

Source: Medical Patent Business Week (2007-05-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry